Sierra Oncology, Inc. Common Stock
SRRA
SRRA was delisted on the 30th of June, 2022.
38 hedge funds and large institutions have $268M invested in Sierra Oncology, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$127M |
| 2 |
O
OrbiMed
New York
|
+$56.1M |
| 3 |
DM
Deerfield Management
New York
|
+$38M |
| 4 |
ASP
Adams Street Partners
Chicago,
Illinois
|
+$32.7M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$24.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citadel Advisors
Miami,
Florida
| $274K | +$377K | +334 | New |
|
27
Geode Capital Management
Boston,
Massachusetts
| $217K | +$300K | +266 | New |
|
|
WMSA
28
Weiss Multi-Strategy Advisers
New York
| $205K | +$282K | +250 | New |
|
|
BG
29
BlackRock Group
London,
United Kingdom
| $198K | +$272K | +241 | New |
|
|
DCM
30
DAFNA Capital Management
Los Angeles,
California
| $174K | +$240K | +213 | New |
|
|
BIM
31
BlackRock Investment Management
Wilmington,
Delaware
| $109K | +$150K | +133 | New |
|
32
Bank of Montreal
Toronto,
Ontario, Canada
| $103K | +$141K | +125 | New |
|
33
Citigroup
New York
| $47K | +$64.3K | +57 | New |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $45K | +$62K | +55 | New |
|
|
BIT
35
BlackRock Institutional Trust
San Francisco,
California
| $8K | +$11.3K | +10 | New |
|
36
UBS Group
Zurich,
Switzerland
| $8K | +$11.3K | +10 | New |
|
37
BNP Paribas Financial Markets
Paris,
France
| $7.98K | +$11.3K | +10 | New |
|
38
Bank of America
Charlotte,
North Carolina
| $7K | +$9.02K | +8 | New |
|
SRRA Hedge Fund Activity: Q3 2015 in Review
38 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q3 2015, worth a combined $268M.
Buyers outnumbered sellers: 38 funds opened new SRRA positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $127M.
- 38 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $268M of Sierra Oncology, Inc. Common Stock stock for Q3 2015.
- 38 funds opened new Sierra Oncology, Inc. Common Stock positions in Q3 2015 and 0 closed out, a net change of +38 holders.
- The largest Sierra Oncology, Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $127M added.
Based on aggregated 13F filings for Q3 2015.